An observational study in Respiratory Failure and Treatment Outcome, sponsored by Haramaya Unversity. Completed at 2 sites in Ethiopia. Open to participants aged 4 Years to 80 Years. Per ClinicalTrials.gov, last updated 2024-02-28.
Sponsored by Haramaya Unversity · Observational
The study was a retrospective observational cohort where patient medical record review was done and data were gathered on 419 cases. The ICU admission pattern and patient outcome were the primary outcomes presented in the manuscript.
The study was conducted at a teaching University hospital in a low-resource setting retrospectively on admission to ICU over the last five years. samples were selected using a simple random sampling technique to come up with the desired number.
1,369 studies on the registry are indexed under Respiratory Insufficiency; 264 are open to participants now.
This study's enrollment of 419 is above the median of 100 across 455 observational studies indexed under Respiratory Insufficiency.
Browse Respiratory Insufficiency studies →Haramaya Unversity is the lead sponsor of 9 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
all patients admitted to ICU of HrU- HFCSH
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Following ICU admission patients are followed until discharge with the outcome of alive or dead
pattern of admission and outcome of patients admitted to the Intensive care Unit of a tertiary hospital in Low resource setting. A cohort study
a retrospective cohort study
Time frame: 1 month
Plan to share: No — IPD will not be exposed
No publications or documents are linked to this record.
This study is completed, as verified in Oct 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Haramaya Unversity